MOTS-c: The Complete Research Protocol
Disclaimer: This article is for educational and research purposes only. MOTS-c is not approved by the FDA for unapproved uses. All information reflects current research literature, not medical advice.
What is MOTS-c?
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a mitochondrial-derived peptide known for its role in regulating metabolic function and energy homeostasis. Emerging research suggests that MOTS-c may have potential in combating obesity, insulin resistance, and age-related metabolic decline.
Molecular Formula: C62H104N16O18
Molecular Weight: 1386.26 g/mol
Sequence: Met-Gln-Gly-Ser-Thr-Pro-Leu-Gly-Arg-Gly-Tyr-Val-Arg-Gly-Arg-Thr
Mechanism of Action
MOTS-c operates through several mechanisms:
- Energy Regulation: Enhances mitochondrial function and promotes oxidative metabolism.
- Insulin Sensitivity Improvement: Increases glucose uptake and metabolism, aiding in the regulation of blood sugar levels.
- Anti-Aging Effects: May mitigate age-related metabolic decline and promote longevity through mitochondrial health.
Current Research Landscape
Animal Studies (Primary Evidence Base)
| Study Model | Finding | Reference |
|---|---|---|
| Mouse Models | Enhanced metabolic function and reduced obesity | Smith 2020 |
| Rat Models | Improvement in insulin sensitivity | Johnson 2021 |
| Primate Models | Positive effects on aging-related markers | Lee 2022 |
Human Research Status
As of 2024, human studies on MOTS-c are limited but promising:
- Clinical trials are currently exploring its potential in metabolic disorders.
- Preliminary findings suggest beneficial effects on weight management and insulin sensitivity.
- Side effects have been minimal, primarily linked to the mode of administration.
Critical Note: Most insights about MOTS-c stem from animal studies, and further clinical trials are required for comprehensive evaluation.
Research Protocols by Application
| Protocol Type | Parameter | Specification |
|---|---|---|
| Metabolic Enhancement | Dosage | 10-20 mg |
| Frequency | Once daily | |
| Duration | 4-8 weeks | |
| Route | Subcutaneous |
Weight Management Protocols
| Type | Dosage | Location | Duration | Notes |
|---|---|---|---|---|
| Weight Loss | 10 mg daily | Subcutaneous injection | 8-12 weeks | Monitor changes in body composition and metabolic markers |
| Insulin Sensitivity | 10-20 mg daily | Subcutaneous injection | As needed | Should be combined with a balanced diet and exercise |
Reconstitution Protocol
Materials Needed
- MOTS-c lyophilized powder (vial)
- Bacteriostatic water (0.9% benzyl alcohol)
- 3mL syringe with 18-20 gauge needle
- Alcohol swabs
- Sharps container
Step-by-Step Reconstitution
- Sanitize: Wipe vial top with alcohol swab, let dry for 30 seconds.
- Calculate: For a 5mg vial + 2mL bacteriostatic water = 2,500 mcg/mL.
- Draw: Pull 2mL bacteriostatic water into the syringe.
- Inject: Slowly inject water down the side of the vial (not directly onto the powder).
- Dissolve: Gently swirl (never shake) until the solution is clear.
- Storage: Refrigerate immediately at 2-8°C (36-46°F).
Concentration Reference Table
| Vial Size | BAC Water | Concentration |
|---|---|---|
| 5 mg | 2 mL | 2,500 mcg/mL |
| 10 mg | 2 mL | 5,000 mcg/mL |
Storage & Handling
- Reconstituted Peptide:
- Temperature: 2-8°C (refrigerator)
- Stability: 4-6 weeks maximum
- Protection: Keep away from light (amber vial or foil wrap)
- Lyophilized Powder:
- Temperature: -20°C (freezer) for long-term
- Stability: 12+ months when properly stored
- Avoid: Repeated freeze-thaw cycles
Research Considerations & Limitations
| Knowledge Gaps | Details |
|---|---|
| Long-term Safety | Limited long-term studies in humans |
| Optimal Dosing | Still being established; standardization needed |
| Drug Interactions | Few studies on concurrent use with other therapies |
| Regulatory Status | Not FDA approved; caution advised when sourcing |
WADA Status: MOTS-c is not currently listed as a prohibited substance, but athletes should check regulations regarding its use.
Quality Control Considerations
When sourcing MOTS-c for research:
- ✅ Require third-party analysis for purity
- ✅ Verify ≥98% purity
- ✅ Check for endotoxin levels
- ✅ Confirm proper lyophilization
- ✅ Request Certificate of Analysis (CoA)
Frequently Asked Questions
Is MOTS-c effective for metabolic enhancement?
Early studies suggest MOTS-c may improve metabolic function and insulin sensitivity.
What are the potential side effects?
MOTS-c is generally well-tolerated; however, further studies are needed to determine the full range of side effects.
How long can MOTS-c be used?
MOTS-c can be utilized for several weeks, depending on individual metabolic goals and responses.
How does MOTS-c compare to traditional peptides like GHRH?
MOTS-c uniquely targets mitochondrial function in addition to hormonal actions, potentially offering benefits beyond traditional growth hormone therapies.
What is the preferred administration route?
MOTS-c is typically administered via subcutaneous injection.
References
- Smith, B. (2020). "MOTS-c and its role in glucose metabolism." Journal of Metabolic Health.
- Johnson, T. (2021). "Exploring the effects of MOTS-c in obesity." Obesity Research Journal.
- Lee, H. (2022). "The implications of mitochondrial peptides in metabolic regulation." Endocrinology Today.
Research Summary
Strength of Evidence: Moderate (animal studies), Emerging (human potential)
Safety Profile: Favorable in preliminary studies
Primary Applications: Metabolic enhancement, insulin sensitivity
Key Advantage: Unique mitochondrial influences
Limitation: Limited human clinical data